Vice Chairwoman Lin, Sarina and CEO, Dr. Chuang, Simon, Shih-Hsien, were invited as the representatives of HoneyBear Biosciences to discuss the initiative and process of the company's founding, how to collaborate and leverage the power of a diverse team, overcome various challenges and difficulties, successfully complete fundraising, and officially launch the company's first project. HoneyBear Biosciences is focusing on developing next-generation drugs to help more patients. Finally, they emphasized: the original intention of establishing HoneyBear Biosciences is to benefit more patients and bring hope for life to those who have no treatment options!
Original article on Startup 101:下世代癌症新藥平台，成為患者的續命希望：專訪嘉正生技 | STARTUP101
Original article on Startup 101:下世代癌症新藥平台，成為患者的續命希望：專訪嘉正生技 | STARTUP101
